Insider buying last 90 days
No open-market insider purchases were filed for MOH in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Molina Healthcare presented at the 2026 UBS Global Healthcare Conference this week, alongside a Form 8-K filed on 6 November. Seasonal returns charts covering the stock's average monthly performance from 2016 to 2026 also circulated, with one version citing a close of 186.10, up 5.41%, though the main listing shows the shares closing at $203.35, down 2.7% on the week.
MOH trades at $203.35, above both its 50-day average of $202.03 and its 200-day average of $185.40, with the shorter-term average sitting above the longer-term one. The one-month return stands at 3.3%, the three-month at 4.5%, and the one-year at 38.2%, against a 52-week range of $121.06 to $244.89. The GekkoIndex reads 58.7, placing the stock in the Neutral zone, while Gekko Fair Value is set at $346.69, leaving the price 41.3% below that level.
The next earnings date falls on 4 February 2027, 86 days out and beyond a typical 20-trading-day holding window; the prior report on 22 July 2026 showed adjusted EPS of $1.51 against an estimate of $1.37, with a -11.6% reaction and an average absolute reaction of 13.7% across recent quarters. No insider, Congress or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged -1% over 5 years, rising in 3 of them. Analyst consensus stands at 12 firms, with a $219.53 price target implying 8% upside.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Molina Healthcare scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
Above 50 and 200-day
Close $209.49 is above the 50-day ($202.58) and 200-day ($185.79) averages, and the 50-day is above the 200-day.
See the chart57.4, Neutral
Reading 57.4 is in the Neutral zone.
See the GekkoIndex38.6% below
Price is 38.6% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 81 days
Next report Feb 4, 2027, 81 days away — outside a typical 20-trading-day hold.
See earnings+6.5% on average
From this point in the calendar, the next 20 trading days averaged +6.5% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Molina Healthcare closed at $209.49 on Nov 13, 2026, +48.5% over the past year, inside a 52-week range of $121.06 to $244.89.
Use the left and right arrow keys to read daily values.
Put MOH on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Molina Healthcare provides managed health care services aimed at lower-income individuals and families. Coverage is delivered through government-backed programs, including Medicaid and Medicare, along with plans offered on state health insurance marketplaces. The company has built its reputation around serving populations that rely on these public health programs rather than employer-based insurance.
The business is structured around four operating segments: Medicaid, Medicare, Marketplace, and an additional Other category. As of the end of 2021, Molina Healthcare served roughly 5.2 million members spread across 18 states, with all of them enrolled through Medicaid, Medicare, or comparable government-sponsored health plans.
Founded in 1980, Molina Healthcare is headquartered in Long Beach, California. Its shares trade on the NYSE under the ticker MOH.
Molina Healthcare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.4, in the Neutral zone, up 2.1 points over five sessions.
Up 2.1 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 75 | −0.8% | −1.8% | ||
| Accumulation | 261 | +0.7% | +1.7% | ||
| Neutral (current zone) | 339 | −0.8% | −1.6% | ||
| Distribution | 25 | +1.4% | −7.8% | ||
| Selling | 2 | Too few readings yet | |||
Average MOH share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Molina Healthcare trades 38.6% below Gekko Fair Value of $340.98, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Molina Healthcare shares are worth, recalculated every trading day.
$340.98
Gekko Fair Value, Nov 14, 2026
38.6% Undervalued
At the end of Aug 2026 the price was 5.2% below the estimate.
No open-market insider purchases were filed for Molina Healthcare, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MOH in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MOH were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Molina Healthcare has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold MOH.
Molina Healthcare reports on Feb 4, 2027 (81 days away), and beat the EPS estimate in 4 of its last 8 reports.
Feb 4, 2027
81 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 22, 2026 | $1.51 est $1.37 | $10.87B est $10.83B | −11.6% |
| Apr 22, 2026 | $2.35 est $1.91 | $10.80B est $10.87B | +15.7% |
| Feb 5, 2026 | −$2.75 est $0.50 | $11.38B est $10.88B | −26.0% |
| Oct 22, 2025 | $1.84 est $3.97 | $11.48B est $11.29B | −18.2% |
| Jul 23, 2025 | $5.48 est $5.62 | $11.43B est $10.95B | −12.4% |
| Apr 23, 2025 | $6.08 est $5.97 | $11.15B est $10.84B | −2.3% |
| Feb 5, 2025 | $5.05 est $5.88 | $10.50B est $10.28B | −9.6% |
| Oct 23, 2024 | $6.01 est $5.94 | $10.34B est $9.91B | +14.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Molina Healthcare is $219.53, +4.8% from the last close, from 12 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 12 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 29 | Wells Fargo | $220 | +5.0% |
| Oct 27 | J.P. Morgan | $225 | +7.4% |
| Oct 26 | Deutsche Bank | $163 | −22.2% |
| Oct 23 | UBS | $225 | +7.4% |
| Oct 23 | Morgan Stanley | $192 | −8.3% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Molina Healthcare averaged +6.5% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.8% | 2 of 5 |
| Next 10 trading days | −1.4% | 2 of 5 |
| Next 15 trading days | +2.2% | 2 of 5 |
| Next 20 trading days | +6.5% | 3 of 5 |
| Next 30 trading days | +5.5% | 3 of 5 |
For scale, MOH’s typical 20-trading-day move in either direction is about 6.3%.
Molina Healthcare’s market cap is $10.94B and revenue of $42.08B over the last twelve months.
Coverage of Molina Healthcare this week reads neutral: 1 positive, 6 neutral and 0 negative headlines.
Molina Healthcare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| UNHUnitedHealth | Neutral | 9.7% above |
| ELVElevance Health | Neutral | 31.3% below |
| CICigna | Neutral | 35.4% below |
| HUMHumana | Neutral | 16.1% below |
| CNCCentene | Neutral | 19.3% below |
| OSCROscar Health | Accumulation | 8.7% below |
A peer links to its own page where one exists.
Molina Healthcare’s market cap is $10.94B at the Nov 13, 2026 close of $209.49, with 52.00M shares outstanding.
The consensus analyst 12-month price target for Molina Healthcare is $219.53, +4.8% from the last close. Of the 12 firms that rated the stock in the last 90 days, 2 rate it a buy, 9 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Molina Healthcare is undervalued: the Nov 13, 2026 close of $209.49 is 38.6% below Gekko Fair Value of $340.98. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Molina Healthcare is expected to report on Feb 4, 2027 (81 days away). Analysts expect earnings of $0.56 per share on revenue of $12.01B. Molina Healthcare beat the earnings estimate in 4 of its last 8 reports, moving 13.7% on average across the report.
Molina Healthcare’s 52-week high is $244.89 and its 52-week low is $121.06; it closed at $209.49 on Nov 13, 2026, +48.5% over the past year. Over the last five years the shares peaked at $423.92 on Mar 27, 2024.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (trend, fair value, earnings risk and seasonality), 1 as mixed (gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.